4-Chloro-2-(4-(ethoxycarbonyl)-1,5-dimethyl-1H-pyrrol-2-yl)benzoic acid, 97%, 250mg

1-(4-Fluoro-2-nitrophenyl)piperidin-4-amine hydrochloride, 95.0%, 1g

9-Phenyl-2,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole>96.0%(HPLC)(N)1g

Ethyl Pentafluoropropionate>98.0%(GC)25g

N-(3-Fluoro-4-methylphenyl)-4-methylbenzenesulfonamide, 95%, 100mg

2-Chloro-4,6-dimethoxy-1,3,5-triazine, 98.0%, 500g

Ethyl 2-chloro-5-iodobenzoate, 95.0%, 250mg

(3aS,8bS)-4-(4-(2,2-diphenylvinyl)phenyl)-1,2,3,3a,4,8b-hexahydrocyclopenta[b]indole-7-carbaldehyde, 98%, 1g

Formic acid, min. 98%, for synthesis, 10 l, plastic packaging.

N,N-Dimethyl-o-toluidine>99.0%(GC)25mL

3-Bromo-4-chloro-5-methoxyaniline, 97%, 1g

2-HYDROXY-2-PHOSPHONO-3-(PYRIDIN-3-YL)PROPANOIC ACID, 95%, 5mg

3-(tert-Butoxycarbonylamino)pyrrolidine, 99.0%, 100g